Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes

Journal of Ovarian Research

Volumn 7, Issue 1, 2014, Pages

  Dolmans, Marie Madeleine ^a   Marotta, Maria Laura ^b   Pirard, Céline ^a   Donnez, Jacques ^c   Donnez, Olivier ^b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c Society for Research Into Infertility SRI   (Belgium)

Author keywords

Embryo cryopreservation; Fertility preservation; Ovarian cortex cryopreservation

Indexed keywords

CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CELL COUNT; CELL ISOLATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CRYOPRESERVATION; EMBRYO FREEZING; EMBRYONAL TISSUE; FEMALE; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; FREEZING; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; METAPHASE; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARIAN TISSUE CRYOPRESERVATION; OVARY HYPERSTIMULATION; YOUNG ADULT; CASE CONTROL STUDY; NEOPLASMS; OOCYTE; OVULATION INDUCTION; PHYSIOLOGY;

ADULT; CASE-CONTROL STUDIES; CRYOPRESERVATION; FEMALE; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; HUMANS; NEOPLASMS; OOCYTE RETRIEVAL; OOCYTES; OVULATION INDUCTION; YOUNG ADULT;

EID: 84908009052     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/s13048-014-0080-8     Document Type: Article

References (32)

1. Donnez J, Martinez-Madrid B, Jadoul P, Van Langendonckt A, Demylle D, Dolmans MM: Ovarian tissue cryopreservation and transplantation: a review. Hum Reprod Update 2006, 12:519-535.
2. Wallace WH, Thomson AB, Kelsey TW: The radiosensitivity of the human oocyte. Hum Reprod 2003, 18(1):117-121.
3. Meirow D: Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol 2000, 169(1-2):123-131.
4. Rienzi L, Cobo A, Paffoni A, Scarduelli C, Capalbo A, Vajta G, Remohí J, Ragni G, Ubaldi FM: Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study. Hum Reprod 2012, 27(6):1606-1612.
5. Cobo A, Garcia-Velasco JA, Domingo J, Remohi J, Pellicer A: Is vitrification of oocytes useful for fertility preservation for age-related fertility decline and in cancer patients? Fertil Steril 2013, 99(6):1485-1495.
6. Cakmak H, Rosen MP: Ovarian stimulation in cancer patients. Fertil Steril 2013, 99(6):1476-1484.
7. Donnez J, Dolmans MM: Fertility preservation in women. Nat Rev Endocrinol 2013, 9(12):735-749.
8. Luyckx V, Scalercio S, Jadoul P, Amorim CA, Soares M, Donnez J, Dolmans MM: Evaluation of cryopreserved ovarian tissue from prepubertal patients after long-term xenografting and exogenous stimulation. Fertil Steril 2013, 100(5):1350-1357.
9. Jadoul P, Dolmans MM, Donnez J: Fertility preservation in girls during childhood: is it feasible, efficient and safe and to whom should it be proposed? Hum Reprod Update 2010, 16(6):617-630.
10. Bedoschi G, Oktay K: Current approach to fertility preservation by embryo cryopreservation. Fertil Steril 2013, 99(6):1496-1502.
11. McLaren JF, Bates GW: Fertility preservation in women of reproductive age with cancer. Am J Obstet Gynecol 2012, 207(6):455-462.
12. Noyes N, Knopman JM, Melzer K, Fino ME, Friedman B, Westphal LM: Oocyte cryopreservation as a fertility preservation measure for cancer patients. Reprod Biomed Online 2011, 23(3):323-333.
13. Jadoul P, Kim SS: ISFP Practice Committee, Fertility considerations in young women with hematological malignancies. J Assist Reprod Genet 2012, 29(6):479-487.
14. Chung K, Donnez J, Ginsburg E, Meirow D: Emergency IVF versus ovarian tissue cryopreservation: decision making in fertility preservation for female cancer patients. Fertil Steril 2013, 99(6):1534-1542.
15. Anderson RA, Wallace WH: Fertility preservation in girls and young women. Clin Endocrinol (Oxf ) 2011, 75(4):409-419.
16. Barcroft J, Dayoub N, Thong KJ: Fifteen year follow-up of embryos cryopreserved in cancer patients for fertility preservation. J Assist Reprod Genet 2013, 30(11):1407-1413.
17. Lawrenz B, Jauckus J, Kupka M, Strowitzki T, von Wolff M: Efficacy and safety of ovarian stimulation before chemotherapy in 205 cases. Fertil Steril 2010, 94(7):2871-2873.
18. Turan V, Bedoschi G, Moy F, Oktay K: Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients. Fertil Steril 2013, 100(6):1681.5.e1.
19. Huober-Zeeb C, Lawrenz B, Popovici RM, Strowitzki T, Germeyer A, Stute P, von Wolff M: Improving fertility preservation in cancer: ovarian tissue cryobanking followed by ovarian stimulation can be efficiently combined. Fertil Steril 2011, 95(1):342-344.
20. Dittrich R, Lotz L, Mueller A, Hoffmann I, Wachter DL, Amann KU, Beckmann MW, Hildebrandt T: Oncofertility: combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval. Reprod Biol Endocrinol 2013, 11:19.
21. Dolmans MM, Demylle D, Martinez-Madrid B, Donnez J: Efficacy of in vitro fertilization after chemotherapy. Fertil Steril 2005, 83(4):897-901.
22. Meirow D, Epstein M, Lewis H, Nugent D, Gosden RG: Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod 2001, 16(4):632-637.
23. Anderson RA, Kinniburgh D, Baird DT: Preliminary experience of the use of a gonadotrophin-releasing hormone antagonist in ovulation induction/ in-vitro fertilization prior to cancer treatment. Hum Reprod 1999, 14(10):2665-2668.
24. Nayak SR, Wakim AN: Random-start gonadotropin-releasing hormone (GnRH) antagonist-treated cycles with GnRH agonist trigger for fertility preservation. Fertil Steril 2011, 96(1):e51-e54.
25. Ozkaya E, San Roman G, Oktay K: Luteal phase GnRHa trigger in random start fertility preservation cycles. J Assist Reprod Genet 2012, 29(6):503-505.
26. von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, Strowitzki T: Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril 2009, 92(4):1360-1365.
27. Bedoschi GM, de Albuquerque FO, Ferriani RA, Navarro PA: Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature. J Assist Reprod Genet 2010, 27(8):491-494.
28. Cakmak H, Katz A, Cedars MI, Rosen MP: Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril 2013, 100(6):1673-1680.
29. Friedler S, Koc O, Gidoni Y, Raziel A, Ron-El R: Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis. Fertil Steril 2012, 97(1):125-133.
30. Tulandi T, Holzer H: Effects of malignancies on the gonadal function. Fertil Steril 2012, 98(4):813-815.
31. Oktay K, Türkçüoʇlu I, Rodriguez-Wallberg KA: GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reprod Biomed Online 2010, 20(6):783-788.
32. Reddy J, Oktay K: Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer. Fertil Steril 2012, 98(6):1363-1369.